相似文献
1
Cross-linking IgE augments human conventional dendritic cell production of CC chemokine ligand 28.
J Allergy Clin Immunol. 2010 Jan;125(1):265-7. doi: 10.1016/j.jaci.2009.09.038. Epub 2009 Dec 4.
2
IL-17A induces CCL28, supporting the chemotaxis of IgE-secreting B cells.
Int Arch Allergy Immunol. 2011;156(1):51-61. doi: 10.1159/000322178. Epub 2011 Mar 29.
3
CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Kidney Int. 2004 Nov;66(5):1907-17. doi: 10.1111/j.1523-1755.2004.00965.x.
4
Human cord blood-derived mast cells synthesize and release I-309 in response to IgE.
Life Sci. 2003 Oct 3;73(20):2571-81. doi: 10.1016/s0024-3205(03)00607-6.
5
Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK.
J Immunol. 2000 Mar 15;164(6):2851-6. doi: 10.4049/jimmunol.164.6.2851.
6
The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
PLoS One. 2015 Jan 30;10(1):e0117904. doi: 10.1371/journal.pone.0117904. eCollection 2015.
7
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
J Immunol. 2004 Apr 15;172(8):4972-6. doi: 10.4049/jimmunol.172.8.4972.
8
Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding.
J Immunol. 2002 May 15;168(10):4871-80. doi: 10.4049/jimmunol.168.10.4871.
9
Membrane-impermeant cross-linking reagents: application to the study of the cell surface receptor for IgE.
Methods Enzymol. 1987;150:503-12. doi: 10.1016/0076-6879(87)50103-3.
10
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
J Immunol. 2005 Apr 15;174(8):5082-91. doi: 10.4049/jimmunol.174.8.5082.
引用本文的文献
1
Neuregulin-1 prevents death from a normally lethal respiratory viral infection.
PLoS Pathog. 2025 Apr 23;21(4):e1013124. doi: 10.1371/journal.ppat.1013124. eCollection 2025 Apr.
2
Epidemiology of Infections and Development of Asthma.
Immunol Allergy Clin North Am. 2019 Aug;39(3):297-307. doi: 10.1016/j.iac.2019.03.001. Epub 2019 Apr 30.
3
Asthma and viral infections: An intricate relationship.
Ann Allergy Asthma Immunol. 2019 Oct;123(4):352-358. doi: 10.1016/j.anai.2019.06.020. Epub 2019 Jul 2.
4
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192.
5
Post-viral atopic airway disease: pathogenesis and potential avenues for intervention.
Expert Rev Clin Immunol. 2019 Jan;15(1):49-58. doi: 10.1080/1744666X.2019.1541737. Epub 2018 Nov 3.
6
Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
Respir Res. 2018 Jun 8;19(1):113. doi: 10.1186/s12931-018-0813-0.
7
Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease.
J Allergy Clin Immunol. 2018 Oct;142(4):1206-1217.e5. doi: 10.1016/j.jaci.2017.11.026. Epub 2017 Dec 18.
8
Respiratory viral infections and atopic development: From possible mechanisms to advances in treatment.
Eur J Immunol. 2018 Mar;48(3):407-414. doi: 10.1002/eji.201747052. Epub 2018 Jan 15.
9
Targeted therapy in severe asthma today: focus on immunoglobulin E.
Drug Des Devel Ther. 2017 Jun 29;11:1979-1987. doi: 10.2147/DDDT.S130743. eCollection 2017.
10
POL7085 or anti-CCL28 treatment inhibits development of post-paramyxoviral airway disease.
Immun Inflamm Dis. 2017 Jun;5(2):98-108. doi: 10.1002/iid3.147. Epub 2017 Feb 2.
本文引用的文献
1
Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Int J Dermatol. 2009 Aug;48(8):822-9. doi: 10.1111/j.1365-4632.2009.04069.x.
2
The causal direction in the association between respiratory syncytial virus hospitalization and asthma.
J Allergy Clin Immunol. 2009 Jan;123(1):131-137.e1. doi: 10.1016/j.jaci.2008.10.042.
3
Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia.
J Exp Med. 2007 Oct 29;204(11):2759-69. doi: 10.1084/jem.20070360. Epub 2007 Oct 22.
4
IL-1beta and TNF-alpha induce increased expression of CCL28 by airway epithelial cells via an NFkappaB-dependent pathway.
Cell Immunol. 2005 Dec;238(2):87-96. doi: 10.1016/j.cellimm.2006.02.003. Epub 2006 Apr 11.
5
Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma.
J Allergy Clin Immunol. 2003 Dec;112(6):1132-8. doi: 10.1016/j.jaci.2003.09.011.
6
A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts.
J Immunol. 2003 Apr 1;170(7):3799-805. doi: 10.4049/jimmunol.170.7.3799.
7
A cohort of children hospitalised with acute RSV bronchiolitis: impact on later respiratory disease.
Paediatr Respir Rev. 2002 Sep;3(3):177-83. doi: 10.1016/s1526-0542(02)00191-4.
8
Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2).
J Biol Chem. 2000 Jul 21;275(29):22313-23. doi: 10.1074/jbc.M001461200.
Zotero 插件